RB

Rashmi Bardhan

Active Director Director DIN 10824214
DIN 10824214 First appointment Oct 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Rashmi Bardhan

Data last updated:

Rashmi Bardhan is a Director at Proavir Pharmaceutical Private Limited (since 2024). The company operates in Paper.

DIN 10824214
Primary Designation Director
Industry Paper
First Appointment 29 Oct 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Oct 20242024Active

Board colleagues of Rashmi Bardhan

NameDINCompanyDesignation
Mohammad Atif11017832Proavir Pharmaceutical Private LimitedAdditional Director
Pankaj Kumar10824213Proavir Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Proavir Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Rashmi Bardhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rashmi Bardhan

Rashmi Bardhan currently holds 1 directorship: Proavir Pharmaceutical Private Limited (Director, since 29 Oct 2024).

Rashmi Bardhan was first appointed on 29 Oct 2024 as Director at Proavir Pharmaceutical Private Limited.

The current boards of Rashmi Bardhan's companies include Mohammad Atif (Proavir Pharmaceutical Private Limited), Pankaj Kumar (Proavir Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available